Acceptance-based Intervention at Colorectal Cancer Patients (ABICOL)
1 de outubro de 2020 atualizado por: George Theodoropoulos, National and Kapodistrian University of Athens
Impact of Perioperative Acceptance-based Intervention on Early Psychological and Fanctional Recovery of Colorectal Cancer Patients
Taking into account the unavoidable effect of a major oncologic surgery commonly required for colorectal cancer patients and the recognized psychological and functional sequelae of the surgical treatment on their status, we will evaluate the influence of a psychological intervention, known as acceptance-based intervention, offered to those patients at the preoperative setting.
Reduction of anxiety and assessmemt of indices of post-intervention psychological and functional recovery will be the primary goals of the study.
Visão geral do estudo
Status
Desconhecido
Intervenção / Tratamento
Descrição detalhada
Introduction: Uncertainty, fears and anxiety are common reactions to an upcoming colectomy for colorectal cancer patients and are related not only to cancer disease, but also to the inevitable change in colon anatomy, affecting their preoperative psychological and functional condition and their postsurgical recovery.
Purpose: We aim to evaluate the psychological and functional recovery of colorectal cancer patients, who undergo colectomy, after an acceptance-based nursing intervention. The scope of this brief preoperative intervention is to enable patients to cope more efficiently with the upcoming surgery and their health status, as it is expected to reduce anxiety and have positive effect on postsurgical psychological and functional recovery.
Methods: The study includes histologically diagnosed patients with colorectal cancer, regardless of stage, who are scheduled to undergo colectomy. Patients will be divided into two groups-the experimental and the control group-by simple randomization. Both groups are going to complete a set of same questionnaires regarding quality of life, sleep, anxiety, depression and functional status. Patients in the control arm will then receive treatment-as-usual while patients in the experimental arm will also receive an acceptance-based intervention before surgery. Postoperatively, for both groups, apart from the self-reported symptoms, we will assess objective recovery factors, such as postoperative complications
Tipo de estudo
Intervencional
Inscrição (Antecipado)
80
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
-
Athens, Grécia, 11528
- Recrutamento
- NKUAthens
-
Contato:
- George Theodoropoulos
- Número de telefone: 6945463593
- E-mail: georgetheocrs@live.com
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
18 anos e mais velhos (Adulto, Adulto mais velho)
Aceita Voluntários Saudáveis
Não
Gêneros Elegíveis para o Estudo
Tudo
Descrição
Inclusion Criteria:
- Patients with histologically proven colorectal adenocarcinoma
- Age > 18 years
Exclusion Criteria:
- Metastasis at time of diagnosis
- Recurrence at time of diagnosis
- History of other malignancies
- Mental retardation
- Deafness
- Illiteracy
- ASA score>3
- Poor performance status
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: ABICOL
24 hours prior to surgery the patients undergo acceptance-based intervention, incorporating questions about their subjective perception about the surgery, the domains of their lives that have been affected, and on their own expectations from surgery and its effects on their lives.
They will be asked to express their fears and worries about their condition and they will be discussed about the likelihood of experiencing postoperative pain.
|
24 hours prior to surgery the patients undergo acceptance-based intervention, incorporating questions about their subjective perception about the surgery, the domains of their lives that have been affected, and on their own expectations from surgery and its effects on their lives.
They will be asked to express their fears and worries about their condition and they will be discussed about the likelihood of experiencing postoperative pain.
|
|
Sem intervenção: CONTROL
No acceptance-based intervention or other discussion related to the patients' fears and worries will be applied.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Postoperative pain as measured by VAS score
Prazo: Third postoperative day
|
A Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured.
The pain VAS is a unidimensional measure of pain intensity, which has been widely used in diverse adult populations.The most simple VAS is a straight horizontal line of fixed length, usually 100 mm.
The ends are defined as the extreme limits of the parameter to be measured orientated from the left (worst) to the right (best).
|
Third postoperative day
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Functional status as measured by "Maintain Function" Scale (MFS)
Prazo: Third postoperative day
|
"Maintain function" scale is a validated 5-item summative.
Each item begins with the stem, "How confidant are you that you know or can," and assesses an aspect of daily life-function, such as work and social activities.
The responses are a 5-level Likert scale from 0 = "not at all confident" to 4 = "completely confident."
We did not include a "not applicable" response option.
The self-efficacy scores range between 0 and 20, with a higher score indicating better self-efficacy to maintain function.
|
Third postoperative day
|
|
Anxiety and depression measured by Brief Illness Perception Questionnaire (Brief IPQ)
Prazo: Third postoperative day
|
The Brief Illness Perception Questionnaire (Brief IPQ) is a 9-item questionnaire designed to rapidly assess cognitive and emotional representations of illness.
The Brief IPQ uses a single-item scale approach to assess perception on a 0-10 response scale.
The Brief IBQ comprises 5 items on cognitive representation of illness perception: consequences, timeline, personal control, treatment control, and identity.
There are 2 items on emotional representation: concern and emotions.
One item is on illness comprehensibility.
The last item is on perceived cause of illness, in which respondents list the three most important causal factors in their illness.
|
Third postoperative day
|
|
Anxiety and depression measured by State-Trait Anxiety (STAI) questionnaire
Prazo: Third postoperative day
|
The State-Trait Anxiety Inventory (STAI) is a psychological inventory based on a 4-point Likert scale and consists of 40 questions on a self-report basis.
The STAI measures two types of anxiety - state anxiety, or anxiety about an event, and trait anxiety, or anxiety level as a personal characteristic.
Higher scores are positively correlated with higher levels of anxiety.
|
Third postoperative day
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Investigadores
- Investigador principal: George E Theodoropoulos, Associate Professor of Surgery
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
22 de junho de 2020
Conclusão Primária (Antecipado)
22 de junho de 2021
Conclusão do estudo (Antecipado)
20 de janeiro de 2022
Datas de inscrição no estudo
Enviado pela primeira vez
16 de setembro de 2020
Enviado pela primeira vez que atendeu aos critérios de CQ
1 de outubro de 2020
Primeira postagem (Real)
5 de outubro de 2020
Atualizações de registro de estudo
Última Atualização Postada (Real)
5 de outubro de 2020
Última atualização enviada que atendeu aos critérios de controle de qualidade
1 de outubro de 2020
Última verificação
1 de outubro de 2020
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- IRB6/26-2-2019
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
SIM
Descrição do plano IPD
Sharing clinical trial data with other professional organizations and researchers will be important element to support best practice principles in our clinical trial.
Prazo de Compartilhamento de IPD
At completion of study and analysis of results
Critérios de acesso de compartilhamento IPD
If requested for universal prospective registration If requested by journals for publication If requested by researchers running similar clinical trials
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- SEIVA
- CIF
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .